Uterine Sarcoma Trial Results
Surgery Alone May Be Best for Early Endometrial Cancer
(Posted: 01/14/2009) - Results from a large international clinical trial show no evidence of benefit in terms of overall or recurrence-free survival for pelvic lymphadenectomy in women with early endometrial cancer, according to the Jan. 10, 2009, issue of the Lancet.
Ifosfamide Plus Paclitaxel Extends Life for Patients With Uterine Carcinosarcoma
(Posted: 03/05/2007) - Women with a rare, aggressive form of uterine cancer who were treated with the drugs ifosfamide and paclitaxel lived a median of five months longer than women who were treated with ifosfamide alone, according to the Feb. 10, 2007, Journal of Clinical Oncology.
(Posted: 01/14/2009) - Results from a large international clinical trial show no evidence of benefit in terms of overall or recurrence-free survival for pelvic lymphadenectomy in women with early endometrial cancer, according to the Jan. 10, 2009, issue of the Lancet.
Ifosfamide Plus Paclitaxel Extends Life for Patients With Uterine Carcinosarcoma
(Posted: 03/05/2007) - Women with a rare, aggressive form of uterine cancer who were treated with the drugs ifosfamide and paclitaxel lived a median of five months longer than women who were treated with ifosfamide alone, according to the Feb. 10, 2007, Journal of Clinical Oncology.
